269 related articles for article (PubMed ID: 23232571)
21. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
22. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
Wang Q; Wang L; L Y; Ding X; Liu A
J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
[TBL] [Abstract][Full Text] [Related]
23. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
24. Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers
Khalique S; Nash S; Natrajan R
J Pathol; 2022 Sep; 258(1):1-3. PubMed ID: 35647895
[TBL] [Abstract][Full Text] [Related]
25. [Endometriosis-related ovarian tumors].
Schmidt D; Ulrich U
Pathologe; 2014 Jul; 35(4):348-54. PubMed ID: 24992974
[TBL] [Abstract][Full Text] [Related]
26. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
Virchows Arch; 2012 Jan; 460(1):77-87. PubMed ID: 22120431
[TBL] [Abstract][Full Text] [Related]
27. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis.
Zou Y; Zhou JY; Guo JB; Wang LQ; Luo Y; Zhang ZY; Liu FY; Tan J; Wang F; Huang OP
Mutat Res; 2018 May; 809():1-5. PubMed ID: 29547736
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology.
Guo SW
Hum Reprod Update; 2020 Apr; 26(3):423-449. PubMed ID: 32154564
[TBL] [Abstract][Full Text] [Related]
29. [Is endometriosis a precancerous lesion? Perspectives and clinical implications].
Chene G; Caloone J; Moret S; Le Bail-Carval K; Chabert P; Beaufils E; Mellier G; Lamblin G
Gynecol Obstet Fertil; 2016 Feb; 44(2):106-12. PubMed ID: 26850282
[TBL] [Abstract][Full Text] [Related]
30. ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.
Yachida N; Yoshihara K; Suda K; Nakaoka H; Ueda H; Sugino K; Yamaguchi M; Mori Y; Yamawaki K; Tamura R; Ishiguro T; Isobe M; Motoyama T; Inoue I; Enomoto T
Sci Rep; 2020 Aug; 10(1):14260. PubMed ID: 32868822
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects.
Ruderman R; Pavone ME
Minerva Ginecol; 2017 Jun; 69(3):286-294. PubMed ID: 28271698
[TBL] [Abstract][Full Text] [Related]
32. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma.
Huang HN; Lin MC; Huang WC; Chiang YC; Kuo KT
Mod Pathol; 2014 Jul; 27(7):983-90. PubMed ID: 24336158
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetic defects in endometriosis.
Thomas EJ; Campbell IG
Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
[TBL] [Abstract][Full Text] [Related]
35. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis.
Guan B; Rahmanto YS; Wu RC; Wang Y; Wang Z; Wang TL; Shih IeM
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24899687
[TBL] [Abstract][Full Text] [Related]
36. ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
[TBL] [Abstract][Full Text] [Related]
37. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
38. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
39. Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series.
Vroobel KM; McCluggage WG
Int J Gynecol Pathol; 2022 Jan; 41(1):76-81. PubMed ID: 33741765
[TBL] [Abstract][Full Text] [Related]
40. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Su YF; Tsai EM; Chen CC; Wu CC; Er TK
Clin Chim Acta; 2019 Jul; 494():1-7. PubMed ID: 30851247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]